The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines

Since the first described human infection with SARS-CoV-2 in December of 2019 many subunit protein vaccines have been proposed for use in humans. Subunit vaccines use one or more antigens suitable for eliciting a robust immune response. However, the major concern is the efficacy of subunit vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadi, Mehrdad, Shayestehpour, Mohammad, Mirzaei, Hamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367756/
https://www.ncbi.nlm.nih.gov/pubmed/34428473
http://dx.doi.org/10.1016/j.bjid.2021.101606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367756/
https://www.ncbi.nlm.nih.gov/pubmed/34428473
http://dx.doi.org/10.1016/j.bjid.2021.101606

Ejemplares similares